$UTHR News

United Therapeutics (UTHR) Stock Looks Cheap On Fair Value Despite Strong Returns

United Therapeutics (UTHR) Following FDA Approval Is The Stock Fully Valued

B of A Securities Maintains Neutral on United Therapeutics, Lowers Price Target to $613

United Therapeutics Stock Rises 14% YTD: Here's What You Need to Know

Is United Therapeutics Corporation (UTHR) Stock a Long-Term Opportunity in Organ Transplant Innovation?

RBC Capital Maintains Outperform on United Therapeutics, Raises Price Target to $704

United Therapeutics: Trifecta Of 2026 Tyvaso Franchise Filings Makes It A Compelling Buy

UTHR Strengthens Regenerative Medicine Platform With Thymmune Deal

United Therapeutics Corporation Acquires Thymmune Therapeutics

United Therapeutics Expands Immune Therapy Pipeline With Thymmune

United Therapeutics Acquired Thymmune Therapeutics For $140M In Cash

The Oliver Patch Project Announces United Therapeutics Corporation Named Visionary/Presenting Sponsor of National Patch Day 2026

FDA Approval Positions United Therapeutics To Broaden Access To Donor Lungs

United Therapeutics Corporation Announces FDA Approval of the LungFX™ Device for Centralized Ex Vivo Lung Perfusion

Q1 Earnings Outperformers: United Therapeutics (NASDAQ:UTHR) And The Rest Of The Therapeutics Stocks

A Look At United Therapeutics (UTHR) Valuation After Strong Long Term Shareholder Returns

Why Is United Therapeutics (UTHR) Down 3.8% Since Last Earnings Report?

How The Story Around United Therapeutics (UTHR) Is Shifting On Trials Pricing And Valuation

SDZNY or UTHR: Which Is the Better Value Stock Right Now?

United Therapeutics Corporation (UTHR) Presents at Jefferies Global Healthcare Conference 2026 Transcript